CD8A and cancer: In accordance with other published studies, CD8+ T cell infiltration was associated with improved survival (See section Materials and Methods) in seven of the 23 cancers (31–36), whereas monocyte/macrophage infiltration exhibited poor survival in seven of the 23 cancers (Figure 3A, Supplementary Table 4).